Cite
HARVARD Citation
Fanikos, J. et al. (2022). Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US. Journal of medical economics. pp. 309-320. [Online].